Key Morningstar Metrics for Albemarle
- : $200.00
- : ★★★
-
Morningstar Economic Moat Rating
: Narrow
-
Morningstar Uncertainty Rating
: Very High
What We Thought of Albemarle’s Earnings
Albemarle ALB reported strong first-quarter results, with higher lithium prices driving nearly 150% year-over-year adjusted EBITDA growth. Albemarle shares were up over 6% at the time of writing on May 7 as the market reacted to the strong results.
Why it matters: Albemarle does not provide companywide guidance, so the market tends to use the company’s most recent results and current lithium spot prices as an indication of profit direction.
- Albemarle tends to set most of its prices a quarter in advance, so with lithium prices rising in the first quarter of 2026 from the fourth quarter of 2025, Albemarle should see sequential profit growth in the second quarter of 2026 and maintain higher profits through the year.
- Lithium prices rallied from multi-year low prices around $8,000 per metric ton in mid-2025 to current spot prices around $21,000 per metric ton. Given Albemarle’s low-cost lithium resources, we expect the company to generate strong profits and free cash flow at this level.
The bottom line: We maintain our $200 fair value estimate for narrow-moat Albemarle. At current prices, we view Albemarle shares as fairly valued, trading near our fair value estimate and in 3-star territory.
- Management plans to take a more disciplined capital allocation approach to growing its lithium capacity even in a higher-price environment. We are in favor of this approach, as it should allow the company to generate positive free cash flow and maintain a strong balance sheet throughout the price cycle.
- We forecast long-term lithium prices around $20,000 per metric ton based on our outlook for supply and demand. We forecast strong growth in electric vehicles and energy storage systems in the coming years, which will require higher-cost supply to meet demand.
Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.
The author or authors do not own shares in any securities mentioned in this article.
Find out about Morningstar’s editorial policies.
Leave a comment